Kacimi SEO, Dehais C, Feuvret L, Chinot O, et al. Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma. J Clin Oncol 2025;43:329-338.
PMID: 39356975